医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

IntelliCentrics Debuts Healthcare’s First COVID-19 Credential

2021年02月08日 AM10:30
このエントリーをはてなブックマークに追加


 

DALLAS

IntelliCentrics (6819.HK), the innovator of the SEC3URE Ethos, SEC3URE Passport, Link & GO! and BioBytes™ serving healthcare facilities across North America, the United Kingdom and China, announces the creation of the industry’s first COVID-19 credential available to all users across its technology platform. This first-of-its-kind solution provides facilities with the data they need to ensure optimal steps are taken for each individual entering the facility.

Healthcare facilities are faced with the challenge of providing a safe environment to both COVID and non-COVID visitors. In order to accomplish this, facilities need to know, who among their visitors have received the COVID-19 vaccine, who have not, with a focus on the frontline healthcare workers. IntelliCentrics’ technology delivers all of this while going a step further by providing necessary insights to manage medically necessary exceptions.

“We relish the fact that our technology supports frontline workers who are most at risk in the battle against COVID-19,” said Michael Sheehan, CEO of IntelliCentrics. “And we understand the best solution needs to be a total solution, so we used our experience and made this work for virtually every possible scenario in the entire care delivery system. The result is that patients can once again receive treatments and have loved ones by their side without feeling vulnerable to the virus.”

When circumstances require, IntelliCentrics’ technology also provides facilities with the ability to set up alternatives such as attestation, screening questions, and PPE requirements as part of their COVID-19 credential. It is a total solution in that it covers all categories of individuals entering the facility and their unique circumstances.

IntelliCentrics’ technology platform currently hosts over 11,000 facilities worldwide, giving facilities the control and communication tools to inform all visitors, from the waiting room to the board room, their role in creating a safe and secure environment. Sheehan added, “the power of our community is in its varied and collective experiences and sharing what we have learned from SARS, H1N1, and all other vaccine-based policies.”

About IntelliCentrics

With a mission to use trust to make high-quality healthcare as accessible as a good cup of coffee, IntelliCentrics created the SEC3URE Ethos. Built on three core principles – transparency, neutrality, and independence, the SEC3URE Ethos is relied on by more than 11,000 locations of care worldwide to ensure mutual trust between patients, doctors, vendor representatives and healthcare companies. To learn more about the world’s largest trusted healthcare technology platform, visit www.intellicentrics.com. To learn more about the COVID-19 vaccine credential, visit our COVID-19 Solution Center. IntelliCentrics is publicly traded on The Stock Exchange of Hong Kong Limited under the stock code 6819.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210207005010/en/

CONTACT

Jennifer Xia

972-316-6523

jxia@intellicentrics.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease